跳至主要内容
临床试验/NCT01155427
NCT01155427已完成不适用

A Systematic Review of Literature on Common Antiretroviral Treatments Against Hepatitis B Virus (HBV)

Bristol-Myers Squibb0 个研究点目标入组 100 人开始时间: 2009年5月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
100
主要终点
Viral load

研究概览

简要总结

The purpose of this study is to support the clinical value of entecavir by assessing the relationship between viral load and histological improvement.

详细描述

Systematic review of prospective clinical trials

研究设计

研究类型
Observational
观察模型
Cohort

入排标准

年龄范围
16 Years 至 —(Child, Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients with CHB diagnosis and no co-infection with Hep A, Hep C, Hep D, or HIV
  • Age 16 years or older
  • No post-transplant patients
  • RCT, non-randomized trials, prospective cohort studies, prospectively analyses case series published since 2003
  • At least one arm of trial must include monotherapy with entecavir, lamivudine, tenofovir, adefovir, or telbivudine
  • Study arms must include at least 10 patients
  • Follow-up of at least 48 weeks
  • Published results available in English language

排除标准

  • 未提供

结局指标

主要结局

Viral load

Histological improvement

次要结局

未报告次要终点

研究者

发起方
Bristol-Myers Squibb
申办方类型
Industry

相似试验